Orion Oyj/€ORNBV
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Orion Oyj
Orion Oyj is a Finnish pharmaceutical and diagnostics company engaged primarily in the research, development, manufacturing, and marketing of pharmaceuticals and active pharmaceutical ingredients. It operates through two main segments: the Pharmaceuticals segment, which includes proprietary drugs, specialty products, and animal health, and the Diagnostics segment, which comprises the Orion Diagnostica company focused on diagnostic tests. Founded in 1917, Orion is headquartered in Espoo, Finland, and operates globally with a significant presence in the Nordic countries and significant partnerships worldwide. Orion's strategic focus includes a strong emphasis on its proprietary drug portfolio, particularly in the central nervous system and oncology sectors, which constitutes a crucial component of its competitive strengths.
Ticker
€ORNBV
Sector
Primary listing
XHEL
Employees
4,132
Headquarters
Espo, Finland
Website
Orion Oyj Metrics
BasicAdvanced
€9.6bn
18.21
€3.76
0.27
€1.72
2.51%
Price and volume
Market cap
€9.6bn
Beta
0.27
52-week high
€76.25
52-week low
€57.30
Average daily volume
9.6k
Dividend rate
€1.72
Financial strength
Current ratio
1.767
Quick ratio
1.126
Long term debt to equity
9.854
Total debt to equity
29.428
Dividend payout ratio (TTM)
43.65%
Interest coverage (TTM)
77.76%
Profitability
EBITDA (TTM)
720.8
Gross margin (TTM)
64.80%
Net profit margin (TTM)
27.11%
Operating margin (TTM)
34.25%
Effective tax rate (TTM)
20.31%
Revenue per employee (TTM)
€470,000
Management effectiveness
Return on assets (TTM)
22.11%
Return on equity (TTM)
48.36%
Valuation
Price to earnings (TTM)
18.207
Price to revenue (TTM)
4.932
Price to book
8.58
Price to tangible book (TTM)
10.32
Price to free cash flow (TTM)
54.63
Free cash flow yield (TTM)
1.83%
Free cash flow per share (TTM)
1.253
Dividend yield (TTM)
2.51%
Growth
Revenue change (TTM)
22.92%
Earnings per share change (TTM)
52.06%
3-year revenue growth (CAGR)
13.15%
10-year revenue growth (CAGR)
6.73%
3-year earnings per share growth (CAGR)
16.29%
10-year earnings per share growth (CAGR)
9.91%
3-year dividend per share growth (CAGR)
4.00%
10-year dividend per share growth (CAGR)
3.31%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs